Search Results - "Stern, A C"

Refine Results
  1. 1

    Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies by Lisboa, Sabrina F., Vila-Verde, C., Rosa, J., Uliana, D. L., Stern, C. A. J., Bertoglio, L. J., Resstel, L. B., Guimaraes, F. S.

    Published in Psychopharmacology (2019)
    “…Rationale Aversive learning and memory are essential to cope with dangerous and stressful stimuli present in an ever-changing environment. When this process is…”
    Get full text
    Journal Article
  2. 2

    Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest by Stern, C.A.J, Do Monte, F.H.M, Gazarini, L, Carobrez, A.P, Bertoglio, L.J

    Published in Neuroscience (29-09-2010)
    “…Abstract The prelimbic (PL) subregion of medial prefrontal cortex has been implicated in anxiety regulation. It is unknown, however, whether PL cortex also…”
    Get full text
    Journal Article
  3. 3

    Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze by Stern, C.A.J., Carobrez, A.P., Bertoglio, L.J.

    Published in Pharmacology, biochemistry and behavior (01-10-2008)
    “…Rodents re-exposed to the elevated plus-maze no longer respond to anxiolytic-like drugs, such as benzodiazepines. This phenomenon is thought to be due to…”
    Get full text
    Journal Article
  4. 4

    Flow Cytometry for Clinical Estimation of Circulating Hematopoietic Progenitors for Autologous Transplantation in Cancer Patients by Siena, Salvatore, Bregni, Marco, Brando, Bruno, Belli, Nadia, Ravagnani, Fernando, Gandola, Lorenza, Stern, Angelika C., Lansdorp, Peter M., Bonadonna, Gianni, Gianni, A. Massimo

    Published in Blood (15-01-1991)
    “…Optimum methods of harvesting circulating hematopoietic progenitors for autologous transplantation to support myelo-ablative cancer therapy are still…”
    Get full text
    Journal Article
  5. 5

    Molecular identification, tissue distribution and subcellular localization of mST3GalV/GM3 synthase by Stern, C A, Braverman, T R, Tiemeyer, M

    Published in Glycobiology (Oxford) (01-04-2000)
    “…A molecular screen for a mouse homologue of a Drosophila carbohydrate binding protein, called Gliolectin, yielded a cDNA encoding mST3GalV/GM3 synthase…”
    Get full text
    Journal Article
  6. 6

    Efficacy and security of ivermectin given orally to rats naturally infected with Syphacia spp., Giardia spp. and Hymenolepis nana by Foletto, VRS, Vanz, F, Gazarini, L, Stern, CAJ, Tonussi, CR

    Published in Laboratory animals (London) (01-07-2015)
    “…The results of this study show that the oral administration of ivermectin (48 mg/L) repeatedly for 72 h used in accordance with the present protocol is a safe…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Accelerates Neutrophil and Monocyte Recovery After Allogeneic T-Cell-Depleted Bone Marrow Transplantation by Witte, T. De, Gratwohl, A., Der Lely, N. Van, Bacigalupo, A., Stern, A.C., Speck, B., Schattenberg, A., Nissen, C., Gluckman, E., Fibbe, W.E.

    Published in Blood (01-03-1992)
    “…In a prospective randomized study, five European transplant centers compared recombinant human granulocyte-macro-phage colony-stimulating factor (rhGM-CSF;…”
    Get full text
    Journal Article
  9. 9

    Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma by Gianni, A M, Bregni, M, Siena, S, Orazi, A, Stern, A C, Gandola, L, Bonadonna, G

    Published in Journal of clinical oncology (01-05-1990)
    “…High-dose administration of anticancer agents is attractive both on theoretic and clinical grounds. Yet, high-dose regimens are usually used as salvage…”
    Get more information
    Journal Article
  10. 10

    Protein synthesis in dorsal hippocampus supports the drug tolerance induced by prior elevated plus-maze experience by Gazarini, L, Stern, C.A.J, Bertoglio, L.J

    Published in Neuroscience (14-04-2011)
    “…Abstract Tolerance to the anxiolytic-like effect of drugs may develop because of a memory derived from prior experience in certain apparatuses such as the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Human Monoclonal Antibodies Neutralizing Cytomegalovirus (CMV) for Prophylaxis of CMV Disease: Report of a Phase I Trial in Bone Marrow Transplant Recipients by Aulitzky, W. E., Schulz, T. F., Tilg, H., Niederwieser, D., Larcher, K., Ostberg, L., Scriba, M., Martindale, J., Stern, A. C., Grass, P., Mach, M., Dierich, M. P., Huber, C.

    Published in The Journal of infectious diseases (01-06-1991)
    “…The safety and pharmacokinetics of the two neutralizing human IgG1 monoclonal antibodies to cytomegalovirus (CMV) SDZ89-104 and 89-109 in bonemarrowtransplant…”
    Get full text
    Journal Article
  13. 13

    A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma by DE VRIES, E. G. E, BIESMA, B, WILLEMSE, P. H. B, MULDER, N. H, STERN, A. C, AALDERS, J. G, VELLENGA, E

    Published in Cancer research (Chicago, Ill.) (1991)
    “…In a placebo-controlled double-blind dose-finding trial, 15 patients with ovarian cancer stage III or IV received daily s.c. 1.5, 3, or 6 micrograms/kg…”
    Get full text
    Journal Article
  14. 14

    Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs by Aglietta, M, Monzeglio, C, Pasquino, P, Carnino, F, Stern, A C, Gavosto, F

    Published in Cancer (15-11-1993)
    “…Administration of granulocyte-macrophage colony stimulating factor (GM-CSF) is followed by a rapid increase in the proliferative activity of the hematopoietic…”
    Get more information
    Journal Article
  15. 15

    Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever by Biesma, B, de Vries, E G, Willemse, P H, Sluiter, W J, Postmus, P E, Limburg, P C, Stern, A C, Vellenga, E

    Published in European journal of cancer (1990) (1990)
    “…30 patients with chemotherapy-related leukopenia (white cells 1.0 x 10(9)/l or lower) and fever (temperature 38.5 degrees C or higher) were treated in a…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cells by Aglietta, M, De Felice, L, Stacchini, A, Petti, M C, Bianchi, A C, Aloe Spiriti, M A, Sanavio, F, Apra, F, Piacibello, W, Stern, A C

    Published in Leukemia (01-11-1991)
    “…Granulocyte-macrophage colony-stimulating factor, (GM-CSF) was given at 8 micrograms/kg daily by continuous i.v. infusion for 72 h to six patients with acute…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy by Gerhartz, H H, Stern, A C, Wolf-Hornung, B, Kazempour, M, Schmetzer, H, Gugerli, U, Jones, T C, Wilmanns, W

    Published in Leukemia research (01-02-1993)
    “…Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was given to 60 patients, in a double-blind, non-prophylactic study of already…”
    Get more information
    Journal Article